You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
News & Press Releases
Stay up-to-date with our latest breakthroughs and our commitment to bringing innovation to the field of electrophysiology.
Johnson & Johnson MedTech Receives FDA Approval for the VARIPULSE™ Pulsed Field Ablation Platform for the Treatment of Atrial Fibrillation
Johnson & Johnson MedTech Completes Pilot Phase Enrollment of OMNY-AF Trial Evaluating Large-Tip, Focal Pulsed Field Ablation OMNYPULSE™ Catheter
ESPN’s Mike Greenbergⁱ Reveals How He Tackled Atrial Fibrillation and Strategically Partners with Johnson & Johnson MedTech to Educate Patients
Biosense Webster Completes Enrollment of Omny-IRE Clinical Trial Investigating the OMNYPULSE™ Large-tip Focal Pulsed Field Ablation Catheter
Biosense Webster Presents Late-Breaking Data from admIRE Clinical Trial at the Heart Rhythm Society Annual Meeting
Biosense Webster to Present Data from 42 Company-Sponsored or Funded Studies, Including PFA and RF Innovation, at Heart Rhythm Society Annual Meeting
Johnson & Johnson MedTech Receives FDA Approval for the VARIPULSE™ Pulsed Field Ablation Platform for the Treatment of Atrial Fibrillation
Johnson & Johnson MedTech Completes Pilot Phase Enrollment of OMNY-AF Trial Evaluating Large-Tip, Focal Pulsed Field Ablation OMNYPULSE™ Catheter
ESPN’s Mike Greenbergⁱ Reveals How He Tackled Atrial Fibrillation and Strategically Partners with Johnson & Johnson MedTech to Educate Patients